Phase
Condition
Cerebral Ischemia
Stroke
Communication Disorders
Treatment
Cathodal Cerebellar tDCS
Semantic Feature Analysis (SFA)
Sham
Clinical Study ID
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Chronic ischemic or hemorrhagic left hemisphere stroke
Fluent speaker of English by self-report
Age 18 or older
6 months post onset of stroke
Diagnosis of aphasia and naming impairment using the Western Aphasia Battery-Revised
Exclusion
Exclusion Criteria:
Lesion in the right cerebellum
Previous neurological disorder (other than stroke) affecting the brain, or any otherneurodegenerative disorder or psychiatric disorder
Seizures during the previous 6 months
Uncorrected visual loss or hearing loss by self-report
Use of medications that lower the seizure threshold (e.g., methylphenidate)
Use of N-methyl-D-aspartate (NMDA) antagonists (e.g., memantine)
>80% correct response on the Philadelphia Naming Testing at baseline
History of brain surgery or any metal in the head
Severely impaired auditory comprehension (lower than 2 on the Comprehension subscoreon the Western Aphasia Battery-Revised)
Severely limited verbal output (lower than 2 on the Spontaneous Speech rating scaleon the Western Aphasia Battery-Revised)
Individuals with severe claustrophobia, cardiac pacemakers or ferromagneticimplants, and pregnant women will be excluded from the MRI portion of the study.
Study Design
Study Description
Connect with a study center
Johns Hopkins Hospital
Baltimore, Maryland 21287
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.